Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-22T08:04:37.377Z Has data issue: false hasContentIssue false
  • English
  • Français

The Management of Depression in Hospital

A Comparative Trial of Desipramine and Imipramine

Published online by Cambridge University Press:  29 January 2018

John Waldron  and
T. J. N. Bates
John Waldron
Affiliation:
Saxondale Hospital, Radcliffe-on-Trent, Nottinghamshire
T. J. N. Bates
Affiliation:
Mapperly Hospital, Nottingham
Get access Rights & Permissions [Opens in a new window]

Extract

Desipramine (Pertofran) is a metabolite of imipramine (Tofranil) originally isolated by Herrmann, Schindler and Pulver (1959) and found to be identical with the synthetic compound G.35025. Animal experiments (Gillette et al., 1961) suggest a more rapid action for desipramine, and the majority of clinical trials to date confirm this impression for humans (e.g. Kline et al., 1962; Krakowski, 1963). Some controlled trials, however, (Azima et al., 1962; Hollister et al., 1963) fail to establish that desipramine is either faster acting or more effective than imipramine.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 111 , Issue 475 , June 1965 , pp. 511 - 516
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Azima, H., Silver, A., and Arthurs, D. (1962). “Effects of G-33040 (Ensidon) and G-35020 (Pertofrane) on depressive states.” Canad. Med. Ass. J., 87, 1224–1228.Google Scholar
Ban, T. A., and Lehmann, H. E. (1962). “Clinical trial with desmethylimipramine (G-35025), a new anti-depressive compound.” Ibid., 86, 1030–1031.Google Scholar
Fleminger, J. J., and Groden, B. M. (1962). “Clinical features of depression and the response to imipramine (Tofranil).” J. Ment. Sci., 108, 101–104.Google Scholar
Gillette, J. R., Dingell, J. V., Sulser, F., Kuntzman, R., and Brodie, B. B. (1961). “Isolation from rat brain of a metabolite product, desmethylimipramine, that mediates the antidepressant activity of imipramine.” Experientia, 17, 417–418.Google Scholar
Hamilton, M. (1960). “A rating scale for depression.” J. Neurol. Neurosurg. Psychiat., 23, 56–62.Google Scholar
Herrmann, B., Schindler, W., and Pulver, R. (1959). “Papierchromatographischer Nachweis von Stoff-wechselprodukten des Tofranil.” Med. exp., 1, 381–385.Google Scholar
Hollister, L. E., Overall, J. E., Johnson, M., Katz, G., Kimbell, I., and Honigfeld, G. (1963). “Evaluation of desipramine in depressive states.” J. New Drugs, 3, 166–171.Google Scholar
Hordern, A., Holt, N. F., Burt, C. G., and Gordon, W. F. (1963). “Amitriptyline in depressive states: phenomenology and prognostic considerations.” Brit. J. Psychiat., 109, 815–825.CrossRefGoogle Scholar
Hutchinson, J. T., and Smedberg, D. (1963). “Treatment of depression: a comparative study of E.C.T. and six drugs.” Ibid., 109, 536–538.Google Scholar
Kiloh, L. G., Ball, J. R. B., and Garside, R. F. (1962). “Prognostic factors in the treatment of depressive states with imipramine.” Brit. med. J., i, 1225–1227.Google Scholar
Kline, N. S., Simpson, G., and Brodie, B. B. (1962). “The clinical application of desmethylimipramine: a new type of antidepressant drug.” Int. J. Neuropharmacol., 1, 55–60.Google Scholar
Krakowski, A. J. (1963). “Treatment of severe depression with desipramine, a metabolite of imipramine.” Amer. J. Psychiat., 120, 494–497.Google Scholar
Kristiansen, E. S. (1961). “Cardiac complications during treatment with imipramine (Tofranil).” Acta Psychiat. et Neurol. Scand., 36, 427–442.CrossRefGoogle Scholar
Martin, Mary E. (1963). “A comparative trial of imipramine and phenelzine in the treatment of depression.” Brit. J. Psychiat., 109, 279–285.Google Scholar
Robin, A. A., and Harris, J. A. (1962). “A controlled comparison of imipramine and electroplexy.” J. Ment. Sci., 108, 217–219.Google Scholar
Schou, Mogens (1962). “Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type.” Acta Psychiat. et Neurol. Scand., 38, 331–336.Google Scholar
Spear, F. G., Hall, P., and Stirland, J. D. (1964). “A comparison of subjective responses to imipramine and tranylcypromine.” Brit. J. Psychiat., 110, 53–55.Google Scholar
Wilson, I. C., Gambill, J. M., and Sandifer, M. G. (1964). Psychosomatics, 5, 88.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.